WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke AEGLEA wurde als Wortmarke am 08.06.2021 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1606874 |
| Länder | 
|
| Basismarke |
Nr. 90138790,
26. August 2020
|
| Anmeldedatum | 08. Juni 2021 |
| Ablaufdatum | 08. Juni 2031 |
Markeninhaber
805 Las Cimas Parkway, Suite 100
Austin TX 78746
US
Austin TX 78746
US
Markenvertreter
1801 East 6th Street, Suite 300
Austin TX 78702
US
Waren und Dienstleistungen
05
Pharmaceutical preparations for the treatment of rare
genetic diseases; pharmaceutical preparations for the
treatment of arginase 1 deficiency; pharmaceutical
preparations for the treatment of cancer; biopharmaceutical
preparations for the treatment of rare genetic diseases;
biopharmaceutical preparations for the treatment of arginase
1 deficiency; biopharmaceutical preparations for the
treatment of cancer; biotherapeutic preparations for the
treatment of rare genetic diseases; biotherapeutic
preparations for the treatment of arginase 1 deficiency;
biotherapeutic preparations for the treatment of cancer;
biotherapeutic preparations and substances for the treatment
of rare genetic diseases; biotherapeutic preparations and
substances for the treatment of arginase 1 deficiency;
biotherapeutic preparations and substances for the treatment
of cancer; enzyme replacement therapy preparations for
medical purposes; pharmaceutical preparations for the
prevention and treatment of infectious diseases and
immunological diseases; biopharmaceutical preparations for
the prevention and treatment of infectious diseases and
immunological diseases; pharmaceutical preparations for the
treatment of homocystinuria; biopharmaceutical preparations
for the treatment of homocystinuria; biotherapeutic
preparations for the treatment of homocystinuria
42
Scientific research in the fields of pharmaceuticals,
biopharmaceuticals, medicine, biologics, biotherapeutics,
biosimilars, enzyme replacement therapeutics, and
therapeutics; medical and scientific research in the field
of pharmaceutical and biopharmaceutical treatment of rare
genetic diseases, arginase 1 deficiency, cancer,
immunological diseases, homocystinuria, and infectious
diseases; providing medical and scientific research
information, consultancy, and advisory services, all in the
fields of pharmaceuticals, biopharmaceuticals, medicine,
biologics, biotherapeutics, biosimilars, enzyme replacement
therapeutics, and therapeutics treatments; design,
engineering, research, development and testing services in
the fields of cancer, rare genetic disease, arginase 1
deficiency treatments, immunological diseases,
homocystinuria, and infectious diseases
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 02. Juni 2023 | 2023/22 Gaz | AU | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 01. Dezember 2022 | 2022/48 Gaz | CA | Ablehnung |
| 28. März 2022 | 2022/13 Gaz | GB | Ablehnung |
| 04. Januar 2022 | 2022/1 Gaz | EM | Ablehnung |
| 16. Dezember 2021 | 2022/2 Gaz | CN | Ablehnung |
| 03. November 2021 | 2021/45 Gaz | AU | Ablehnung |
| 06. September 2021 | 2021/37 Gaz | IN | Ablehnung |
| 08. Juni 2021 | 2021/30 Gaz | US | Eintragung |
ID: 141606874